280 related articles for article (PubMed ID: 32388620)
1. Higher anhedonia during withdrawal from initial opioid exposure is protective against subsequent opioid self-administration in rats.
Swain Y; Muelken P; Skansberg A; Lanzdorf D; Haave Z; LeSage MG; Gewirtz JC; Harris AC
Psychopharmacology (Berl); 2020 Aug; 237(8):2279-2291. PubMed ID: 32388620
[TBL] [Abstract][Full Text] [Related]
2. Pioglitazone attenuates the opioid withdrawal and vulnerability to relapse to heroin seeking in rodents.
de Guglielmo G; Kallupi M; Scuppa G; Demopulos G; Gaitanaris G; Ciccocioppo R
Psychopharmacology (Berl); 2017 Jan; 234(2):223-234. PubMed ID: 27714428
[TBL] [Abstract][Full Text] [Related]
3. Locomotor activity does not predict individual differences in morphine self-administration in rats.
Swain Y; Muelken P; LeSage MG; Gewirtz JC; Harris AC
Pharmacol Biochem Behav; 2018 Mar; 166():48-56. PubMed ID: 29409807
[TBL] [Abstract][Full Text] [Related]
4. Behavioral predictors of individual differences in opioid addiction vulnerability as measured using i.v. self-administration in rats.
Swain Y; Gewirtz JC; Harris AC
Drug Alcohol Depend; 2021 Apr; 221():108561. PubMed ID: 33588371
[TBL] [Abstract][Full Text] [Related]
5. Intracranial self-stimulation reward thresholds during morphine withdrawal in rats bred for high (HiS) and low (LoS) saccharin intake.
Holtz NA; Radke AK; Zlebnik NE; Harris AC; Carroll ME
Brain Res; 2015 Mar; 1602():119-26. PubMed ID: 25582876
[TBL] [Abstract][Full Text] [Related]
6. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
Liu J; Schulteis G
Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
[TBL] [Abstract][Full Text] [Related]
7. R-(-)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder
Witkin JM; Kranzler J; Kaniecki K; Popik P; Smith JL; Hashimoto K; Sporn J
Pharmacol Biochem Behav; 2020 Jul; 194():172927. PubMed ID: 32333922
[TBL] [Abstract][Full Text] [Related]
8. Effects of high-dose selegiline on morphine reinforcement and precipitated withdrawal in dependent rats.
Grasing K; He S
Behav Pharmacol; 2005 Feb; 16(1):1-13. PubMed ID: 15706133
[TBL] [Abstract][Full Text] [Related]
9. The antidepressant agomelatine attenuates morphine-induced reinstatement but not self-administration or precipitated withdrawal.
De A; Grasing KW
Pharmacol Biochem Behav; 2023 Feb; 223():173525. PubMed ID: 36758685
[TBL] [Abstract][Full Text] [Related]
10. Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures.
Harris AC; Hanes SL; Gewirtz JC
Psychopharmacology (Berl); 2004 Nov; 176(3-4):266-73. PubMed ID: 15164157
[TBL] [Abstract][Full Text] [Related]
11. Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast).
Hutchinson MR; Lewis SS; Coats BD; Skyba DA; Crysdale NY; Berkelhammer DL; Brzeski A; Northcutt A; Vietz CM; Judd CM; Maier SF; Watkins LR; Johnson KW
Brain Behav Immun; 2009 Feb; 23(2):240-50. PubMed ID: 18938237
[TBL] [Abstract][Full Text] [Related]
12. A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.
Harris AC; Pentel PR; Burroughs D; Staley MD; Lesage MG
Psychopharmacology (Berl); 2011 Sep; 217(2):153-66. PubMed ID: 21494791
[TBL] [Abstract][Full Text] [Related]
13. Oleoyl alanine (HU595): a stable monomethylated oleoyl glycine interferes with acute naloxone precipitated morphine withdrawal in male rats.
Ayoub SM; Smoum R; Farag M; Atwal H; Collins SA; Rock EM; Limebeer CL; Piscitelli F; Iannotti FA; Lichtman AH; Leri F; Di Marzo V; Mechoulam R; Parker LA
Psychopharmacology (Berl); 2020 Sep; 237(9):2753-2765. PubMed ID: 32556401
[TBL] [Abstract][Full Text] [Related]
14. Trait-like impulsivity does not predict escalation of heroin self-administration in the rat.
McNamara R; Dalley JW; Robbins TW; Everitt BJ; Belin D
Psychopharmacology (Berl); 2010 Dec; 212(4):453-64. PubMed ID: 20689939
[TBL] [Abstract][Full Text] [Related]
15. Methocinnamox Produces Long-Lasting Antagonism of the Behavioral Effects of
Gerak LR; Minervini V; Latham E; Ghodrati S; Lillis KV; Wooden J; Disney A; Husbands SM; France CP
J Pharmacol Exp Ther; 2019 Nov; 371(2):507-516. PubMed ID: 31439807
[TBL] [Abstract][Full Text] [Related]
16. Chronic opioid exposure differentially modulates oxycodone self-administration in male and female rats.
Mavrikaki M; Lintz T; Constantino N; Page S; Chartoff E
Addict Biol; 2021 May; 26(3):e12973. PubMed ID: 33078503
[TBL] [Abstract][Full Text] [Related]
17. Effects of environmental enrichment on self-administration of the short-acting opioid remifentanil in male rats.
Hofford RS; Chow JJ; Beckmann JS; Bardo MT
Psychopharmacology (Berl); 2017 Dec; 234(23-24):3499-3506. PubMed ID: 28916995
[TBL] [Abstract][Full Text] [Related]
18. Effects of Acute and Repeated Administration of Oxycodone and Naloxone-Precipitated Withdrawal on Intracranial Self-Stimulation in Rats.
Wiebelhaus JM; Walentiny DM; Beardsley PM
J Pharmacol Exp Ther; 2016 Jan; 356(1):43-52. PubMed ID: 26491062
[TBL] [Abstract][Full Text] [Related]
19. Association between initial morphine intake and body weight change, acoustic startle reflex and drug seeking in rats.
Le T; Xia M; Jia M; Sarkar N; Chen J; Li H; Wynn GH; Ursano RJ; Choi KH
Psychopharmacology (Berl); 2014 Dec; 231(23):4569-77. PubMed ID: 24819733
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
